中富電路(300814.SZ):“新增年產40萬平方米線路板改擴建項目”延期
格隆匯1月18日丨中富電路(300814.SZ)公佈,雖然募投項目已在前期經過了充分的可行性論證,但實際投入過程中受新冠疫情多點爆發以及部分地區的封控政策影響,項目設備採購、物流運輸以及人員流動均存在一定限制,導致項目整體建設進度滯後,項目投資進度放緩。其中,項目的部分產能已於2021年末建成達產,生產的部分產品已小批量投入市場;項目剩餘部分的主體建築已完成,尚處於裝修和設備安裝階段,整體項目無法在原定計劃的時間內完成建設。公司根據募投項目當前的實際建設進度,經審慎研究,擬將“新增年產40萬平方米線路板改擴建項目”的建設期截止時間調整至2023年6月30日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.